Visualizing loss of heterozygosity in living mouse cells and tissues

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 645, Issue 1-2, 2008, Pages 1-8

  Fischer, Jared M ^a   Stringer, James R ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Embryonic stem cells; Intestinal epithelia; Loss of heterozygosity; Mutation; Short hairpin RNA; Yellow fluorescent protein

Indexed keywords

MESSENGER RNA; SHORT HAIRPIN RNA; YELLOW FLUORESCENT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLASTOCYST; CELL LINE; CELL POPULATION; CELL TYPE; EMBRYONIC STEM CELL; GENE LOCUS; GENETIC CODE; HETEROZYGOSITY LOSS; INTESTINE EPITHELIUM CELL; INTESTINE VILLUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION;

ANIMALS; BASE SEQUENCE; DNA PRIMERS; EMBRYONIC STEM CELLS; EPITHELIAL CELLS; INTESTINE, SMALL; LOSS OF HETEROZYGOSITY; LUMINESCENT PROTEINS; MICE; MICE, TRANSGENIC; MICROSCOPY, FLUORESCENCE; RNA INTERFERENCE; RNA, MESSENGER;

MUS; MUS MUSCULUS;

EID: 53349147062     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2008.07.009     Document Type: Article

References (45)

1. Scrable H.J., Witte D.P., Lampkin B.C., and Cavenee W.K. Chromosomal localization of the human rhabdomyosarcoma locus by mitotic recombination mapping. Nature 329 (1987) 645-647
2. Cavenee W.K., Dryja T.P., Phillips R.A., Benedict W.F., Godbout R., Gallie B.L., Murphree A.L., Strong L.C., and White R.L. Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature 305 (1983) 779-784
3. Knudson A.G. Cancer genetics. Am. J. Med. Genet. 111 (2002) 96-102
4. Thiagalingam S., Foy R.L., Cheng K.H., Lee H.J., Thiagalingam A., and Ponte J.F. Loss of heterozygosity as a predictor to map tumor suppressor genes in cancer: molecular basis of its occurrence. Curr. Opin. Oncol. 14 (2002) 65-72
5. Strahm B., and Malkin D. Hereditary cancer predisposition in children: genetic basis and clinical implications. Int. J. Cancer 119 (2006) 2001-2006
6. Cavenee W.K. Mechanisms of p53 loss in human sarcomas. Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 5863-5867
7. Masuda H., Miller C., Koeffler H.P., Battifora H., and Cline M.J. Rearrangement of the p53 gene in human osteogenic sarcomas. Proc. Natl. Acad. Sci. U.S.A. 84 (1987) 7716-7719
8. Groden J., Thliveris A., Samowitz W., Carlson M., Gelbert L., Albertsen H., Joslyn G., Stevens J., Spirio L., Robertson M., Sergeant L., Krapcho K., Wolff E., Burt R., Hughes J.P., Warrington J., McPherson J., Wasmuth J., Le Paslier D., Abderrahim H., Cohen D., Leppert M., and White R. Identification and characterization of the familial adenomatous polyposis coli gene. Cell 66 (1991) 599-600
9. Fearon E.R., Hamilton S.R., and Vogelstein B. Clonal analysis of human colorectal tumors. Science 238 (1987) 193-197
10. Cavenee W.K., Koufos A., and Hansen M.F. Recessive mutant genes predisposing to human cancer. Mutat. Res. 168 (1986) 3-14
11. Zhang J., Lindroos A., Ollila S., Russell A., Marra G., Mueller H., Peltomaki P., Plasilova M., and Heinimann K. Gene conversion is a frequent mechanism of inactivation of the wild-type allele in cancers from MLH1/MSH2 deletion carriers. Cancer Res. 66 (2006) 659-664
12. Fishel R., Lescoe M.K., Rao M.R., Copeland N.G., Jenkins N.A., Garber J., Kane M., and Kolodner R. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 75 (1993) 1027-1038 (published erratum appears in Cell 1994 April 8;77(1):167)
13. Haverty P.M., Fridlyand J., Li L., Getz G., Beroukhim R., Lohr S., Wu T.D., Cavet G., Zhang Z., and Chant J. High-resolution genomic and expression analyses of copy number alterations in breast tumors. Genes Chromosomes Cancer 47 (2008) 530-542
14. Cervantes R.B., Stringer J.R., Shao C., Tischfield J.A., and Stambrook P.J. Embryonic stem cells and somatic cells differ in mutation frequency and type. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 3586-3590
15. Shao C., Deng L., Henegariu O., Liang L., Raikwar N., Sahota A., Stambrook P.J., and Tischfield J.A. Mitotic recombination produces the majority of recessive fibroblast variants in heterozygous mice. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 9230-9235
16. van Sloun P.P., Wijnhoven S.W., Kool H.J., Slater R., Weeda G., van Zeeland A.A., Lohman P.H., and Vrieling H. Determination of spontaneous loss of heterozygosity mutations in Aprt heterozygous mice. Nucleic Acids Res. 26 (1998) 4888-4894
17. Rose J.A., Yates P.A., Simpson J., Tischfield J.A., Stambrook P.J., and Turker M.S. Biallelic methylation and silencing of mouse Aprt in normal kidney cells. Cancer Res. 60 (2000) 3404-3408
18. Winton D.J., Blount M.A., and Ponder B.A. A clonal marker induced by mutation in mouse intestinal epithelium. Nature 333 (1988) 463-466
19. Tao K.S., and Heddle J.A. The accumulation and persistence of somatic mutations in vivo. Mutagenesis 9 (1994) 187-191
20. Yu J., and McMahon A.P. Reproducible and inducible knockdown of gene expression in mice. Genesis 44 (2006) 252-261
21. Srinivas S., Watanabe T., Lin C.S., William C.M., Tanabe Y., Jessell T.M., and Costantini F. Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus. BMC Dev. Biol. 1 (2001) 4
22. Hogan B., Constantini F., and Lacey E. Manipulating the Mouse Embryo. A Laboratory Manual (1986), Cold Spring Harbor Laboratory, Cold Spring Harbor, New York
23. Larson J.S., Yin M., Fischer J.M., Stringer S.L., and Stringer J.R. Expression and loss of alleles in cultured mouse embryonic fibroblasts and stem cells carrying allelic fluorescent protein genes. BMC Mol Biol. 7 (2006) 36
24. Sambrook J.F., Fristch E.F., and Maniatis T. Molecular Cloning: A Laboratory Manual (1989), Cold Spring Harbor Laboratory, Cold Spring Harbor
25. Zambrowicz B.P., Imamoto A., Fiering S., Herzenberg L.A., Kerr W.G., and Soriano P. Disruption of overlapping transcripts in the ROSA beta geo 26 gene trap strain leads to widespread expression of beta-galactosidase in mouse embryos and hematopoietic cells. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 3789-3794
26. Borgdorff V., Hees-Stuivenberg S., Meijers C.M., and de Wind N. Spontaneous and mutagen-induced loss of DNA mismatch repair in Msh2-heterozygous mammalian cells. Mutat. Res. 574 (2005) 50-57
27. Mortensen R.M., Conner D.A., Chao S., Geisterfer-Lowrance A.A., and Seidman J.G. Production of homozygous mutant ES cells with a single targeting construct. Mol. Cell Biol. 12 (1992) 2391-2395
28. Donahue S.L., Lin Q., Cao S., and Ruley H.E. Carcinogens induce genome-wide loss of heterozygosity in normal stem cells without persistent chromosomal instability. Proc. Natl. Acad. Sci. 103 (2006) 11642-11646
29. Chan M.F., van Amerongen R., Nijjar T., Cuppen E., Jones P.A., and Laird P.W. Reduced rates of gene loss, gene silencing, and gene mutation in Dnmt1-deficient embryonic stem cells. Mol. Cell Biol. 21 (2001) 7587-7600
30. Yusa K., Horie K., Kondoh G., Kouno M., Maeda Y., Kinoshita T., and Takeda J. Genome-wide phenotype analysis in ES cells by regulated disruption of Bloom's syndrome gene. Nature 429 (2004) 896-899
31. Luo G., Santoro I.M., McDaniel L.D., Nishijima I., Mills M., Youssoufian H., Vogel H., Schultz R.A., and Bradley A. Cancer predisposition caused by elevated mitotic recombination in Bloom mice. Nat. Genet. 26 (2000) 424-429
32. Dobrovolsky V.N., Casciano D.A., and Heflich R.H. Development of a novel mouse tk+/- embryonic stem cell line for use in mutagenicity studies. Environ. Mol. Mutagen. 28 (1996) 483-489
33. Zhu L., Chang D.W., Dai L., and Hong Y. DNA damage induced by multiwalled carbon nanotubes in mouse embryonic stem cells. Nano Lett. 7 (2007) 3592-3597
34. Griffiths D.F.R., Davies S.J., Williams D., Williams G.T., and Williams E.D. Demonstration of somatic mutation and colonic crypt clonality by X-linked enzyme-histochemistry. Nature 333 (1988) 461-463
35. Winton D.J., and Ponder B.A.J. Stem-cell organization in mouse small-intestine. Proc. R. Soc. Lond. Ser. B-Biol. Sci. 241 (1990) 13-18
36. Lefebvre L., Dionne N., Karaskova J., Squire J.A., and Nagy A. Selection for transgene homozygosity in embryonic stem cells results in extensive loss of heterozygosity. Nat. Genet. 27 (2001) 257-258
37. Wynter C.V. The dialectics of cancer: a theory of the initiation and development of cancer through errors in RNAi. Med. Hypotheses 66 (2006) 612-635
38. Zheng L., Flesken-Nikitin A., Chen P.L., and Lee W.H. Deficiency of Retinoblastoma gene in mouse embryonic stem cells leads to genetic instability. Cancer Res. 62 (2002) 2498-2502
39. Longo L., Bygrave A., Grosveld F.G., and Pandolfi P.P. The chromosome make-up of mouse embryonic stem cells is predictive of somatic and germ cell chimaerism. Transgenic Res. 6 (1997) 321-328
40. Dobrovolsky V.N., McGarrity L.J., Morris S.M., and Heflich R.H. Detection of mutation in transgenic CHO cells using green fluorescent protein as a reporter. Mutat. Res. 518 (2002) 55-64
41. Dobrovolsky V.N., and Heflich R.H. On the use of the T-REx tetracycline-inducible gene expression system in vivo. Biotechnol. Bioeng. 98 (2007) 719-723
42. Ikawa M., Yamada S., Nakanishi T., and Okabe M. Green fluorescent protein (GFP) as a vital marker in mammals. Curr. Top. Dev. Biol. 44 (1999) 1-20
43. Kisseberth W.C., Brettingen N.T., Lohse J.K., and Sandgren E.P. Ubiquitous expression of marker transgenes in mice and rats. Dev. Biol. 214 (1999) 128-138
44. Turker M.S., Lasarev M., Connolly L., Kasameyer E., and Roessler D. Age-related accumulation of autosomal mutations in solid tissues of the mouse is gender and cell type specific. Aging Cell 6 (2007) 73-86
45. Wiktor-Brown D.M., Hendricks C.A., Olipitz W., and Engelward B.P. Age-dependent accumulation of recombinant cells in the mouse pancreas revealed by in situ fluorescence imaging. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 11862-11867